Anna Bennett has a daughter with cystic fibrosis. She hopes MPs get answers to the questions she has about access to the medicine her child needs.
Read MoreIn her second blog on our Plan B campaign Anna, the mother of a child who needs Orkambi, takes a look at Vertex’s behaviour around the world.
Read MoreAnna - mum to a three year old with cystic fibrosis - reflects on the whirlwind start to our campaign to win access to Orkambi.
Read MoreAfter a campaign engaging thousands Dunise won the fight for access to this breast cancer drug at a fair price for the NHS!
Read MoreOne of the inspirational leaders who helped get Just Treatment get off the ground has very sadly passed away.
Read MoreWe’re calling for government action to stop the greed of pharma company Vertex endangering the lives of cystic fibrosis patients like Luis.
Read MoreIt’s time our governments challenge the pharmaceutical industry and put patients’ needs at the heart of our medical innovation model.
Read MoreClare explains why our new report on pharma R&D matters to patients like her.
Read MoreWe won an award for being brilliant!
Read MoreWe had to wait years to access hep C treatment because it was so expensive. This World Hepatitis Day we’re launching our new hep C campaign - Too Long to Wait.
Read MoreHelp us take on big pharma and defend the NHS.
Read MoreDrug companies like Pfizer charge such high prices that patients like me can’t access the drugs we need. They must be challenged.
Read MoreToday we took 5,000 signatures to the Scottish parliament demanding a Crown use licence for breast cancer drug pertuzumab.
Read MoreTwo breast cancer patients share their experiences of trying to access treatment in the UK and South Africa.
Read MoreMSP Alison Johnstone has this week been questioning the Scottish Health Secretary on our campaign.
Read MoreDoes health research and development really cost as much as the drug industry tells us?
Read MorePfizer say their high prices are justified. I’m a patient and this is why I disagree.
Read MoreJoin Dunise’s campaign for fair access to pertuzumab
Read MoreSwiss drug company Novartis has been aggressively putting its' profits before the health of patients.
Read MoreThis R&D model isn't working: Pfizer's decision shows we need to think again about how we develop new drugs.
Read More